drugset / Trial / NCT00116532
Escitalopram for the Treatment of Obsessive Compulsive Disorder (OCD)
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to assess the efficacy of Escitalopram in the treatment of obsessive compulsive disorder and to determine the optimal treatment dose.
Timeline
- Start
- 2002-10
- Primary completion
- —
- Completion
- 2007-02
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Escitalopram | Small molecule | 10 mg | — |
| Subject | Escitalopram | Small molecule | 20 mg | — |
| Subject | Escitalopram | Small molecule | 30 mg | — |